经皮颅骨神经射频消融术治疗头痛疾病：为患者提供的一个有前景的选择。
Radiofrequency Ablation of Pericranial Nerves for Treating Headache Conditions: A Promising Option for Patients.
作者信息
Abd-Elsayed Alaa, Kreuger Laura, Wheeler Shawna, Robillard Janet, Seeger Susanne, Dulli Douglas
机构信息
Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI.
The University of Wisconsin Madison Graduate School, Medical School, Madison, WI.
出版信息
Ochsner J. 2018 Spring;18(1):59-62.
BACKGROUND
Chronic daily headache, including chronic migraine, can be challenging to treat. Medications often only provide limited improvement, and surgical interventions can be associated with significant adverse effects. We present our experience with using radiofrequency ablation (RFA) for pericranial nerves to treat chronic headache conditions.
METHODS
This retrospective analysis included patients who received RFA for pericranial nerves to treat chronic daily headache conditions from January 1, 2015 to June 1, 2016. Outcomes were pain scores as measured on the visual analog scale (with 0 representing no pain and 10 representing the worst pain imaginable) and the patient-reported percent improvement in headache conditions, including pain scores, severity, duration, frequency, and associated symptoms.
RESULTS
Of the 57 patients who received 72 RFAs for pericranial nerves to treat headache or pericranial neuralgia, 90.3% of patients had improvement in their headache condition after receiving RFA. In addition, pain scores decreased from 6.6 ± 1.7 preprocedure to 1.9 ± 1.9 postprocedure (<0.001).
CONCLUSION
Our study demonstrates the efficacy and safety of RFA in treating pericranial neuralgias associated with chronic daily headache.
背景
慢性每日头痛，包括慢性偏头痛，治疗起来可能具有挑战性。药物治疗通常仅能带来有限的改善，而手术干预可能会伴有明显的不良反应。我们介绍了使用射频消融术（RFA）治疗颅周神经以治疗慢性头痛病症的经验。
方法
这项回顾性分析纳入了2015年1月1日至2016年6月1日期间接受RFA治疗颅周神经以治疗慢性每日头痛病症的患者。结局指标为视觉模拟量表测量的疼痛评分（0表示无疼痛，10表示可想象到的最严重疼痛）以及患者报告的头痛病症改善百分比，包括疼痛评分、严重程度、持续时间、频率和相关症状。
结果
在57例接受72次RFA治疗头痛或颅周神经痛的颅周神经患者中，90.3%的患者在接受RFA后头痛病症有所改善。此外，疼痛评分从术前的6.6±1.7降至术后的1.9±1.9（<0.001）。
结论
我们的研究证明了RFA治疗与慢性每日头痛相关的颅周神经痛的有效性和安全性。
Zotero 插件